The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Absolutely not trying to defend. It's taken far too long. But if people read the filing and presentation instead if moaning and expecting info handed on a plate to them then they will have a better understanding of what's happening.
Do you read filings at all? I suggest you do and you will see what's happening in Accustem. Or even a quick trip to their website to read their presentation will give you an idea what the plan is.
As you say in you almost daily posts..
Maybe it's as if someone had been employed to raise the profile of the company and boost the SP..!! But as you say.. They don't need to employ someone to do this.. Especially not an ex plumber who knows more about the companies and has put more effort in over the years than anyone on here..
https://twitter.com/TizianaLS/status/1621077038168948742?t=Kuz3SEYVaFPBs9GHVXkk7w&s=19
https://twitter.com/TizianaLS/status/1617581325615087616?t=kjNUUqT9PVdo8RLmb6WzoQ&s=19
Accustem S1A
https://fintel.io/doc/sec-accustem-sciences-inc-1850767-s1a-2023-january-19-19376-862
Think you are getting ahead of yourself. Please read the latest investor deck on the website about SPMS patients and their expected enrolment. Enrolment does not mean they have received their first dose. They have to have all of their baseline work done first.
https://twitter.com/TizianaLS/status/1616167316831485964?t=eTltkpR0IXXFTS1GaFOftg&s=19
Yes the demerger has taken time. But looking at the state of the markets, would you of really wanted to IPO in this.? Just to watch it potentially go down from IPO day? I certainly wouldn't.
As for other comments you have made, I certainly can't comment any more.
BTW I'm no longer known as Paul the plumber.
Yes, they did mention that it would dual list off the bat. We were all following what the company said at the time. Things have obviously changed direction and the whole market is terrible for an IPO.
With the S1 filing last month I'm sure they are not far off from full listing.
And in answer to your question.. Yes I have, and will continue to buy. Just like you have from your post below.
We are very pleased with the results and plan to include them in our request for a Phase 2 Multiple Sclerosis (MS) Type C meeting with the FDA before year-end, with feedback expected in the first quarter of 2023.
https://ir.tizianalifesciences.com/news-releases/news-release-details/tiziana-life-sciences-announces-completion-prerequisite-pre
Depends if original holding was in nasdaq or LSE. Nasdaq got 10-1